MedTrace Logo

Exparel Infiltration in Anterior Cruciate Ligament Reconstruction

NCT02606448 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2023-12-08

No results posted yet for this study

Summary

This is a randomized, single blinded, standard of care controlled clinical trial. All adult patients over sixteen desiring anterior cruciate ligament reconstruction will be eligible. The study compares pain control and opioid consumption in patients undergoing ACL reconstruction between patients receiving liposomal bupivacaine and those who underwent a preoperative femoral nerve block.

Conditions

Interventions

DRUG

Liposomal bupivacaine

Local infiltration of liposomal bupivacaine

PROCEDURE

Femoral nerve block

Pre-operative femoral nerve block

DRUG

Ropivacaine

Ropivicaine was used in all femoral nerve blocks

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-09-30
Completion
2015-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02606448 on ClinicalTrials.gov